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Dengue remains the most important and the most rapidly spreading arthropod-borne viral disease of human beings [1]. After an incubation period of 4-10 days, infection by 
any of the four virus serotypes circulating in India can produce a 
wide spectrum of clinical manifestations from subclinical to fatal 
infections [2]. India is in the group of countries with the highest 
annual dengue infection rate (7.5-32.5 million). Misdiagnosis 
is contributing to the big disparity between actual and reported 
numbers of dengue infection [3]. Although clinical studies have 
reported on dengue in India, these are largely based on the 
diagnosis made by kits of doubtful specificity and sensitivity [2].
The laboratory diagnosis of dengue is influenced by the 
methods used, the day post onset of symptoms (DPO), and the 
ordinal of the infection. Reverse transcription polymerase chain 
reaction detects dengue virus in the first 5 DPO and is 80-90% 
sensitive, and >95% specific. A negative result is indeterminate. 
Dengue NS1 antigen can be detected from 1 DPO to 18 DPO [4]. 
NS1 enzyme-linked immunosorbent assay (ELISA) tests have 
72.8-86% sensitivity and 100% specificity. Sensitivity drops 
to below 50% by 7 DPO. Sensitivity is higher in primary 
infection (98.8%) than in secondary infections (83.5%) [5]. NS1 
immunochromatography strip’s sensitivity is higher in primary 
infections (94.7%) than in secondary infections (67.1%) [6]. Anti-
dengue immunoglobulin M (IgM) can be detected from 5 DPO to 
2-3 months after the illness. Low titers in secondary dengue result 
in some false-negative cases. IgM ELISAs have 61.5-99.0% 
sensitivity and 79.9-97.8% specificity. However, IgM rapid 
diagnostic tests (RDT) have variable sensitivity (20.5-97.7%) and 
specificity (76.6-90.6%) [7]. A negative IgG in the acute phase 
and a positive IgG in the convalescent phase indicate primary 
dengue. A positive IgG in the acute phase and a 4 fold rise in IgG 
titer in the convalescent phase indicate secondary dengue [4].
Children are at greater risk of severe dengue than adults [8]. 
The risk of mortality of children aged 1-5 years due to dengue 
fever is four-fold higher than in children aged 11-15 years. 
Dengue case fatality rate (CFR) is 0.8-2.5% [9]. CFR in India 
was 3-5% compared to 1% in the South-East Asian region, 0.2% 
in Thailand, and 1.2% in Americas [1]. CFR can be reduced to 
less than 1% by halting the progression from nonsevere to severe 
disease by early, intravenous rehydration [1]. Pediatric dengue 
(PD) poses challenges in its early identification as laboratory 
diagnosis is influenced by many factors. Misdiagnosis can 
be fatal as time to death after the onset of shock is 12-36 h, if 
untreated [8]. More detailed explanation of clinical features such 
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as abdominal pain, tender hepatomegaly, respiratory distress, 
shock, and rash is necessary. Strengthening the evidence base, 
on which support and control planning decisions and their impact 
are evaluated, is essential in India. Hence, we planned to study 
clinical and investigational manifestations of PD, both confirmed 
and unconfirmed, and to compare both the groups for validity of 
clinical diagnosis.
METHODS
It was a retrospective study conducted by reviewing medical 
records of children in the age group 1 month-15 years admitted 
with clinical dengue and confirmed dengue from June to 
November 2015 at the Institute of Child Health, Niloufer 
Hospital, Hyderabad. Medical records were looked for evidence 
of clinical dengue and serological results. Records without 
clinical evidence of dengue were excluded from the study. On 
the basis of evaluation of the history, physical examination 
and/or full blood count and hematocrit, according to the WHO 
guidelines, patients were divided into clinical or confirmed 
dengue groups.
The patients admitted with clinical features of dengue with 
no serological evidence were included in the clinical dengue 
group [1]. The patients with serological evidence of dengue 
(positive NS1 antigen and/or anti-dengue IgM, and/or anti-dengue 
IgG) along with clinical features of dengue were included in the 
confirmed group. Positive IgG alone cases with clinical features 
of dengue were also included in the confirmed dengue group. 
Patients underwent NS 1 Ag testing with RDT kits at the time of 
admission while IgM and IgG testing for dengue was done by Alere 
SD BIOLINE dengue IgG/IgM rapid immunochromatographic 
test after 5 days of fever.
The data were recorded from case records in predesigned 
format which included 3 demographic, 32 symptom, 24 sign, and 
24 investigation entries. Frequencies of individual findings were 
tabulated using SPSS software. Proportions of individual findings 
of both confirmed (Group A) and clinical dengue (Group B) were 
compared for any statistically significant differences. Binary 
logistic regression analysis was done to assess factors associated 
with increased mortality. Periodical clinical and laboratory 
problem listing of patients is better than attempting at dengue 
classification [10]. Hence, these manifestations are listed in detail 
in this study.
RESULTS
Total pediatric admissions at Niloufer Hospital for the year 
2015 were 18,203, of which 13,750 were from 01-06-2015 
to 30-11-2015. Of these 13750 records, we could trace 282 
confirmed dengue cases, 407 clinical dengue cases, 4 confirmed 
dengue deaths, and 24 clinical dengue deaths making a total of 
717 dengue records. CFR, when confirmed and unconfirmed 
cases were taken together, was 4.06 % (95% confidence interval: 
2.56-5.57). Demography, presenting symptoms, signs observed, 
and results of investigations collected from the case records are 
presented in Tables 1-6. As some medical records did not have 
sub-details documented, the numbers of records with documented 
sub-details were presented separately. Wherever details or sub-
details were not present in the patient, or not available in the 
record, they were left blank in the tables.
Serology of 282 children of the confirmed group showed 65 
had IgM, 45 IgG, 67 NS1, 50 had both IgM and IgG, 29 both 
IgM and NS1, and 15 had both IgG and NS1 positive results and 
11 showed positive results for all the three (IgM, IgG, and NS1) 
tests. Of the four confirmed deaths, 2 were IgM and NS1 positive, 
1 was NS1 positive, and another was IgG positive.
Comparison of proportions of individual clinical details 
of the total cases between the confirmed and clinical dengue 
groups yielded no statistically significant differences (p>0.05) in 
all entries including age group and sex distributions except for 
rural-urban proportions, diarrhoea, cold, cough, hypotension, 
decreased urine output, wheezing, decreased platelet count, 
Table 1: Demography of children admitted with dengue
Demographic 
characters
Confirmed cases, n (%) Unconfirmed cases, n (%) Confirmed deaths, n (%) Unconfirmed deaths, n (%)
Total cases 282 407 4 24
Age group
1 month-1 year 43 (15.2) 49 (12.4) 2 (50) 10 (41.7)
1-5 year 87 (30.9) 144 (35.4) 2 (50) 11 (45.8)
6-10 year 117 (41.5) 165 (40.5) 0 3 (12.5)
11-15 year 35 (12.4) 49 (12.4) 0 0
Sex
Male 159 (56.4) 225 (55.3) 1 (25) 9 (37.5)
Female 123 (43.6) 182 (44.7) 3 (75) 15 (62.5)
Residential area
Urban 117 (41.5) 237 (58.2) 1 (25) 10 (41.7)
Semi urban 16 (5.67) 13 (3.2) 5 (20.8)
Rural 148 (52.5) 156 (38.3) 3 (75) 8 (33.3)
Missing data 1 (0.35) 1 (0.24) 1 (4.2)
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Table 2: Symptoms of children admitted with dengue
Symptoms Confirmed dengue Unconfirmed dengue Confirmed deaths Unconfirmed deaths
n (%) Mean±SD 
(range)
n (%) Mean±SD 
(range)
n (%) Mean±SD 
(range)
n (%) Mean±SD 
(range)
Total cases 282 407 4 24
Fever duration 
(days)
282 (100) 5.22±2.17 (1-15) 399 (98) 4.91±2.67 (1-15) 4 (100) 3.33 (3-4) 21 (87.5) 3.9±3.24 (0.1-15)
Vomiting 
(frequency/day)
163 (57.8) 3.41±2.14 (1-10) 220 (54) 3.88±2.72 (1-20) 2 (50) 3 (2-4) 11 (45.8) 4.3±2.54 (2-10)
Diarrhoea 
(frequency/day)
20 (7.1) 4.86±2.5 (2-10) 50 (12.3) 5.21±2.6 (2-150 0 - 2 (8.3) 6 (2-10)
Seizures duration 17 (6) 9.7±8.23  
(0.5-30)
28 (6.9) 6.66±3.28 
(0.2-30)
3 (75) 15 (7.1) 14 (58.3) 15.75±18.83  
(3-600)
Generalized 17 (100) 27 (96.4) 2 (66.6) 13 (92.8)
Partial 0 1 (3.6) 1 (33.3)
Table 3: Symptoms of children admitted with dengue
Symptoms n (%) Confirmed dengue Unconfirmed dengue Confirmed deaths Unconfirmed deaths
Total cases 282 407 4 24
Abdominal pain present 124 (44) 185 (45.4)
Site (data available) 73 97
Right upper quadrant 48 (65.7) 69 (71.1)
Epigastrium 14 (19.2) 14 (14.4)
Left upper quadrant 1 (1.4)
Periumbilical 7 (9.6) 11 (11.3)
Right lower quadrant - 1 (1)
Right lower and left lower 1 (1.4) 1 (1)
Epigastrium and periumbilical 1 (1.4) -
All areas 1 (1.4) 1 (1)
Bleeding manifestations
Gum bleed 2 (0.7) 1 (0.24) 2 (8.3)
Epistaxis 20 (7.1) 19 (4.7) 1 (25) 1 (4.2)
Malena 79 (28) 104 (25.5) 2 (50) 5 (20.8)
Hematuria 10 (3.5) 11 (2.7) 1 (4.2)
Hematemesis 1 (0.3) 9 (2.2) 1 (4.2)
Rash 79 (28) 91 (22.4) 1 (4.2)
Ecchymosis 3 (1) 3 (0.74) 1 (4.2)
Itching 9 (3.2) 17 (4.2)
Respiratory distress 11 (3.9) 23 (5.6) 1 (25) 5 (20.8)
Altered sensorium 3 (1) 4 (1) 3 (75) 13 (54.2)
Giddiness 3 (1) 6 (1.5)
Jaundice 3 (1) 1 (0.25)
Headache 42 (14.9) 76 (18.7)
Cold 30 (10.6) 82 (20.1) 6 (25)
Cough 47 (16.7) 115 (28.2) 9 (37.5)
Excessive cry 5 (1.8) 8 (2)
Swelling 16 (6) 34 (8.3) 1 (4.2)
Decreased urine output 15 (5.7) 14 (3.4) 3 (12.5)
Burning micturition 2 (0.7) 12 (3) 1 (4.2)
Myalgia 49 (17.4) 75 (18.4)
Joint pain 7 (2.5) 12 (3)
Eye pain 2 (0.7) 3 (0.74)
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and hyperchloremia (p<0.05). These differences stemmed from 
unintentional grouping of milder dengue into unconfirmed group 
as less severe cases were less investigated. The proportions of the 
findings in death groups could not be compared as the sample size 
was small.
Serology kits using IgM immunochromatography tested 
at the institute have low sensitivity of 36.2% (156 positives 
of 430 cases tested), falling in the lower range of 20.5-97.7% 
sensitivity of similar kits [7]. Sensitivity of the NS1 RDT kits 
was 80.6% (125 positives of 155 cases tested). Clinical and 
other laboratory details were similar between both the groups 
for nearly 90% of the symptoms, signs, and investigations. 
This necessitates the understanding by the clinicians of the 
superiority of clinical diagnostic skills over laboratory reliance 
for confirmation.
Logistic regression test was done to explore the predictors 
of mortality in these patients and results are shown in Table 7. 
Hosmer and Lemeshow goodness-of-fit test resulted in Chi-square 
Table 4: Signs noticed in children admitted with dengue
Signs, n (%) Confirmed dengue Unconfirmed dengue Confirmed deaths Unconfirmed deaths
Total cases 282 407 4 24
Skin rash 158 (56) 218 (53.6) 8 (33.3)
Flushing 144 (91.1) 193 (88.5) 8 (33.3)
Petechial spots 7 (4.4) 9 (4.1)
Flushing and petechial spots 5 (3.2) 7 (3.2)
Erythematous popular rash 0 7 (3.21)
Missing detail 2 (1.3) 2 (0.92)
Congested Conjunctiva 16 (5.7) 33 (8.1) 2 (8.3)
Sub-conjunctival hemorrhage 1 (0.35) 1 (0.25)
Pallor 10 (3.5) 25 (6.1) 2 (50) 4 (16.7)
Icterus 3 (1) 4 (1) 1 (4.2)
Edema 55 (19.5) 67 (16.5) 2 (50) 6 (25)
Cool peripheries 20 (7.1) 38 (9.3) 1 (25) 12 (50)
Prolonged capillary refill time 12 (4.25) 11 (2.7) 1 (25) 5 (20.8)
Elevated JVP 3 (1) 7 (1.7)
Bradycardia 13 (4.6) 18 (4.4) 8 (33.3)
Decreased urine output 25 (8.9) 15 (3.7) 1 (4.2)
Respiratory distress 3 (1) 14 (3.4) 3 (75) 6 (25)
Wheezing 5 (1.8) 34 (8.3) 2 (50) 6 (25)
Crepitations 4 (1.4) 14 (3.4) 2 (50) 7 (29.2)
Stridor - 1 (0.25) - 1 (4.2)
Hepatomegaly 198 (70.2) 276 (67.8) 2 (50) 19 (79.2)
Tender Hepatomegaly 123 (62.1) 160 (58) 1 (50) 2 (10.5)
Dehydration 1 (0.35) 7 (1.7) 1 (25) 4 (16.7)
Some 1 (100) 6 (85.7) 1 (25) 3 (75)
Severe 0 1 (14.3) 1 (25)
Spleenomegaly 16 (5.7) 24 (5.9) 2 (8.3)
Muscle tenderness 12 (4.25) 8 (2)
Altered sensorium 2 (0.7) 1 (0.25) 4 (100) 14 (58.3)
Meningeal signs 0 0 3 (12.5)
Table 5: BP details noticed in children admitted with dengue
BP Confirmed dengue Unconfirmed dengue Confirmed deaths Unconfirmed deaths
n (%) Mean±SD 
(range)
n (%) Mean±SD 
(range)
n (%) Mean±SD 
(range)
n (%) Mean±SD (range)
Total cases 282 407 4 24
Hypotension (duration in h) 181 (64.2) 44.21±31.28 
(1-144)
204 (50.1) 47.13±40.4 
(0.5-264)
2 (50) 39 (6-72) 14 (58.3) 18.5±15.35 (5-42)
Systolic BP<70 mmHg 25 (13.8) 26 (12.7) 1 (25) 6 (25)
Systolic BP>70 mmHg 154 (85.1) 176 (86.3) 1 (25) 4 (16.7)
Hypertension 1 (0.35) 1 (0.25) 1 (4.2)
BP: Blood pressure
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of 7.792 and a nonsignificant difference between observed and 
estimated outcomes (p=0.454). As p>0.05, this model passes the 
test. Age <5 years, seizures, altered sensorium, bradycardia, and 
systolic blood pressure <70 mmHg were significantly associated 
with increased mortality in dengue.
DISCUSSION
Age distribution of affected children shows that in infancy, 
6-9 months age group, the period of waning passive immunity, 
is the peak period of dengue affection. There were less cases in 
the 1-1.5 year age group, and after this age, there was a small rise 
in the incidence. This is in concordance with previous studies. 
Infants born to dengue-immune mothers had higher risk of 
severe disease, even though it was their first infection [11,12]. 
Table 6: Laboratory results of children admitted with dengue
Investigations, positive/available results (%) Confirmed cases Unconfirmed cases Confirmed deaths Unconfirmed deaths
Total cases 282 407 4 24
Thrombocytopenia (<1,00,000/μL) 225/277 (81.23) 233/370 (63) 2/3 (66.7) 8/13 (61.5)
Leukopenia (<4000/μL) 52/277 (18.77) 57/370 (15.4) 0 0
High PCV (>20%) 51/161 (31.68) 81/192 (42.19) 1/1 (100) 2/2 (100)
Elevated APTT 3/4 (75) 3/5 (60) 1/1 (100)
INR>1.3 34/40 (85) 51/62 (82.2) 3/3 (100) 4/6 (66.7)
Proteinuria 15 38 1
Elevated bilirubin 5/41 (12.2) 8/63 (12.7) 1/2 (50) 2/3 (66.6)
Elevated AST 6/7 (85.7) 2/5 (40) 1/1 (100) 2/2 (100)
Elevated ALT 12/17 (70.6) 16/35 (45.7) 2/2 (100)
Hypoalbuminemia 3/20 (15) 2/30 (6.7)
Elevated creatinine 3/101 (3) 3/149 (4.5) 1/7 (14.3)
Elevated blood urea 10/103 (9.7) 7/150 (4.7) 3/9 (33.3)
Hyponatremia 10/99 (10.1) 8/146 (5.5)
Hypernatremia 1/99 (1) 2/146 (1.4) 1/9 (11.1)
Hypokalemia 4/99 (4) 12/147 (8.2)
Hyperkalemia 2/99 (2) 4/147 (2.7)
Hyperchloremia 20/49 (40.8) 10/63 (15.9) 4/8 (50)
Hypocalcemia 3/11 (27.3) 1/12 (8.3)
Hypoglycemia 2/41 (4.9) 0 
Hyperglycemia 2/41 (4.9) 3/49 (6.1) 2/5 (40)
AST: Aspartate aminotransferase, ALT: Alanine transaminase, PCV: Packed cell volume
Nearly 90% of dengue deaths occurred in children aged <5 years 
emphasizing that this age group needs high priority care. CFR 
in girls was 5.9% (95% CI: 3.17-8.63), and in boys, it was 2.6% 
(95% CI: 0.99-4.22), however, the difference was not significant. 
There is evidence in literature that female sex predisposes to 
severe dengue [13]. Rural areas were no less affected than urban 
areas due to adaptation of urban lifestyle, pointing to the need 
for training and strengthening primary care and proper referral 
system.
Presenting symptoms with >5% frequency in the decreasing 
order were fever, vomiting, abdominal pain, malena, skin rash, 
cough, myalgia, headache, cold, diarrhea, swelling of body, 
epistaxis, seizures, decreased urine, and respiratory distress. Few 
infants with tender hepatomegaly presented with excessive cry 
due to sudden liver enlargement. Seizures (27% died, p=0.047) 
Table 7: Binary logistic regression analysis of risk of mortality in dengue
Variable Standard error of coefficient p value Odds ratio 95% confidence interval
Lower Upper
Age<5 years 0.878 0.008 10.108 1.808 56.510
Female sex 0.684 0.255 2.179 0.570 8.327
Bleeding 0.749 0.443 0.563 0.130 2.444
Seizures 0.798 0.047 4.892 1.024 23.361
Altered sensorium 1.022 0.000 266.218 35.932 1972.364
Bradycardia 0.811 0.000 36.551 7.452 179.278
Respiratory distress 0.951 0.096 4.862 0.755 31.331
Hypotension 0.791 0.887 1.119 0.237 5.276
Systolic BP<70 mmHg 0.996 0.020 10.085 1.433 70.979
BP: Blood pressure
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and altered sensorium (70% died, p=0.000) were associated 
with increased mortality mostly in under five age group 
(p=0.008). Majority of the children complained of pain in right 
hypochondrium (66-71%) followed by epigastrium (14-19%) 
pointing to liver enlargement and gastritis. In children <5 years 
(especially infants), who presented with respiratory infections 
resembling bronchiolitis and gastroenteritis, hepatomegaly and 
flushing served as differentiating findings.
Observed signs with >5% frequency in decreasing order 
were hepatomegaly, hypotension, rash, edema, cool peripheries, 
conjunctival congestion, decreased urine output, wheezing, 
splenomegaly and pallor. Isolated symptom or sign presentations 
of dengue are also seen during epidemics. Cool peripheries, 
prolonged CRT, pallor, elevated jugular venous pressure (JVP), 
and wheezing were less documented in the case records, though 
their observed frequencies at bedside were much higher than 
the presented results. Nearly one-third of patients had elevation 
of JVP persisting for 24-48 h indicating transient myocardial 
dysfunction.
A large body of clinical and experimental evidence points to 
the involvement of liver in pathobiology of dengue infections. The 
hepatocytes are directly involved in infection as a site of dengue 
replication, possibly adding to the total viral burden [14]. Nearly 
70% had hepatomegaly, 60% of the enlarged livers were tender in 
this study. Similar evidence states that liver is palpably enlarged 
in up to 75% of patients, with variable splenomegaly [15]. Tender 
hepatomegaly has few differential diagnoses and can be used 
to diagnose PD. Tender hepatomegaly is rare in malaria [16]. 
Hepatomegaly is usually observed in enteric fever after the first 
week of illness in contrast to dengue, and only 12% of enlarged 
livers were tender in complicated multi-drug resistant enteric 
fever. Hepatomegaly is 2-3 times less common in paratyphoid 
fever than enteric fever [17]. Tender liver in viral hepatitis and 
liver abscess is not associated with early shock or rash. Tender 
liver in congestive cardiac failure presents with abnormal cardiac 
examination findings. Budd-chiari syndrome presents with 
localized findings associated with tender hepatomegaly.
Liver enlargement in dengue posed a problem of appreciation 
because of its soft consistency, especially in under five age 
group. This can be overcome using the method of pressing the 
middle finger tangential to the abdominal surface checking for 
differential resistance in all the quadrants of the abdomen. It was 
observed by the authors at bedside that, using this method, we 
get hepatomegaly frequency near to 100% in PD. Tenderness 
is influenced by the day on which patient is examined after 
hepatomegaly had set in. Tenderness usually decreased after 
3 days of presentation.
Blanchable flushing of the skin with centrifugal distribution, 
predominantly affecting hands and feet was the commonest pattern 
of rash. Truncal, neck, and facial flushing were less commonly 
noticed, probably due to skin color of the children. The lateral 
border of the sole was the consistent site of noticeable flushing. 
Flushing becomes more prominent when feet are in dependent 
position. As many Indian children have pallor, appreciation of 
flushing requires expertise.
High yielding laboratory results in the decreasing order of 
frequency were INR >1.3, thrombocytopenia, elevated APTT, 
increased packed cell volume >20%, hyperchloremia and 
leukopenia. Common findings in ECG were bradycardia and 
low voltage QRS complexes. Common findings on USG were 
hepatomegaly, gall bladder wall edema, and free fluid in peritoneal 
cavity, pleural effusion and splenomegaly. Chest radiographs 
showed hyperinflation as the most frequent finding followed by 
effusions, and perihilar nonhomogenous opacities. Abdominal 
radiography had shown hepatomegaly sometimes reaching 
up to right iliac fossa in nearly 100% patients. A combination 
of hyperinflation and hepatomegaly on radiograph has very 
few differential diagnoses; hence, can be used in the epidemic 
scenario as a definite feature of PD where skilled ultrasonography 
reporting is not available.
Comparison of the results of Groups A and B shows that 
clinical diagnosis is as good as having confirmation. This infers 
that treating patients with fluids according to dengue protocol 
and other supportive measures need not wait for confirmation. 
Confirmatory laboratory studies serve the purpose of confirmation 
of epidemics. Unfortunately, an ideal diagnostic test that permits 
early and rapid diagnosis, is affordable for different health 
systems, is easy to perform, and has a robust performance, is not 
yet available [1]. Except rapid tests, all other methods require 
1 day to 2 weeks’ time and are of no use for case management as 
time to death is narrow once patient is in deterioration. Similar 
guidelines regarding acting on suspicion without waiting for 
confirmation were issued for rickettsial infections by Centers for 
Disease Control and Prevention [18].
The differential diagnosis of dengue includes rickettsial 
infections and relapsing fever. Filoviruses, yellow fever virus, 
bunyaviruses, and arenaviruses can cause increased vascular 
permeability and acute shock, and their treatment is supportive as 
it is in dengue. Clinicians who consistently look for the features 
listed above can get familiarized with the way to diagnose dengue 
in no time and serve the patient in the hour of need.
CONCLUSIONS
These data support that clinical diagnosis is as good as having 
confirmation of dengue. Clinical diagnosis in light of the 
epidemiology using right hypochondrium pain, malena, tender 
hepatomegaly, centrifugal blanchable flushing, and hypotension 
as definite pointers of dengue avoids vagueness. Rapid tests are 
not mandatory, and other laboratory methods cannot serve in the 
hour of need. Laboratory confirmation serves epidemiological 
purposes. Supportive treatment, timely escalation of fluid 
therapy for clinical dengue is more essential than confirmation. 
Further studies should include clinical dengue reporting to avoid 
under-reporting.
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